Endocrine

Pharmacology of GLP-1 Agonists

1. Introduction: The Incretin Effect To understand GLP-1 agonists, one must first understand the "Incretin Effect." This physiological phenomenon describes

By Pharmacology Mentor

Pharmacotherapy of Type 1 Diabetes Mellitus

Introduction Type 1 diabetes mellitus (T1DM) is a complex autoimmune disorder requiring comprehensive pharmacological management throughout the patient's lifetime. Since

By Pharmacology Mentor

Pharmacotherapy of Type 2 Diabetes

Introduction Type 2 Diabetes Mellitus (T2DM) has become a global health challenge, characterized by insulin resistance and a relative deficiency of insulin secretion,

By Pharmacology Mentor
Chat Support